Science Explorer Back to mapMap
Discussion
Company · Leiden · Netherlands

BioMarin (Netherlands)

biomarin.comROR OpenAlex
Research works
18
▼ 79% vs 2018-21
Citations
623
34.6 per fractional work
Top-10% rate
6.9%
all institutions 10.0%
Open access
63%
world 40%
International
25%
world 18%
BioMarin (Netherlands)

Not ranked overall: BioMarin (Netherlands) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does BioMarin (Netherlands) work in?

In all years, 69% of research at BioMarin (Netherlands) is in Life Sciences, 25% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (58%), Medicine (24%), Neuroscience (10%). It does 2.7× the world's share of Life Sciences.

Life Sciences: 12 fractional works · 69.4% of its workBiochemistry, Genetics and Molecular Biology: 10 fractional works · 57.8% of its workMolecular Biology: 10 fractional works · 53.3% of its workGenetics: 1 fractional works · 3.2% of its workCancer Research: 0 fractional works · 0.7% of its workCell Biology: 0 fractional works · 0.6% of its workNeuroscience: 2 fractional works · 9.5% of its workCellular and Molecular Neuroscience: 2 fractional works · 9.3% of its workDevelopmental Neuroscience: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 1.8% of its workPharmacology: 0 fractional works · 1.8% of its workAgricultural and Biological Sciences: 0 fractional works · 0.3% of its workPlant Science: 0 fractional works · 0.3% of its workHealth Sciences: 4 fractional works · 24.8% of its workMedicine: 4 fractional works · 24.3% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 5.4% of its workGenetics: 1 fractional works · 4.9% of its workPhysiology: 1 fractional works · 3.7% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 2.1% of its workSurgery: 0 fractional works · 1.8% of its workOncology: 0 fractional works · 1.4% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.2% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.7% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.6% of its workUrology: 0 fractional works · 0.6% of its workPsychiatry and Mental health: 0 fractional works · 0.5% of its workHematology: 0 fractional works · 0.4% of its workRehabilitation: 0 fractional works · 0.4% of its workEpidemiology: 0 fractional works · 0.3% of its workHealth Professions: 0 fractional works · 0.5% of its workComplementary and Manual Therapy: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysical Sciences: 1 fractional works · 4.4% of its workEngineering: 1 fractional works · 3.1% of its workBiomedical Engineering: 1 fractional works · 3.1% of its workMaterials Science: 0 fractional works · 0.9% of its workBiomaterials: 0 fractional works · 0.9% of its workEnvironmental Science: 0 fractional works · 0.3% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.3% of its workSocial Sciences: 0 fractional works · 1.4% of its workPsychology: 0 fractional works · 0.8% of its workDevelopmental and Educational Psychology: 0 fractional works · 0.8% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.6% of its workEconomics and Econometrics: 0 fractional works · 0.6% of its workALL ITS WORKBioMarin(Netherlands)18fractional works, all years
Life Sciences69%Physical Sciences4%Health Sciences25%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 11 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1057.8%
    2. Neuroscience29.5%
    3. Pharmacology, Toxicology and Pharmaceutics01.8%
    4. Agricultural and Biological Sciences00.3%
    1. Medicine424.3%
    2. Health Professions00.5%
    1. Engineering13.1%
    2. Materials Science00.9%
    3. Environmental Science00.3%
    1. Psychology00.8%
    2. Economics, Econometrics and Finance00.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from BioMarin (Netherlands)?

The most cited paper from BioMarin (Netherlands) is "Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib" (Lisa A. Carey, Donald A. Berry, Constance Cirrincione et al., 2015), with 442 citations. Next come "Benchmarking of commercially available CHO cell culture media for antibody production" (146) and "Use of capillary Western immunoassay (Wes) for quantification of dystrophin levels in skeletal muscle of healthy controls and individuals with Becker and Duchenne muscular dystrophy" (136).

Most cited papers
#PaperReleasedCitations
1 Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib Lisa A. Carey, Donald A. Berry, Constance Cirrincione et al. · Journal of Clinical Oncology Open access 2 Nov 2015 442
2 Benchmarking of commercially available CHO cell culture media for antibody production David Reinhart, Lukas Damjanovic, Christian Kaisermayer et al. · Applied Microbiology and Biotechnology Open access 5 Apr 2015 146
3 Use of capillary Western immunoassay (Wes) for quantification of dystrophin levels in skeletal muscle of healthy controls and individuals with Becker and Duchenne muscular dystrophy Chantal Beekman, Anneke A. M. Janson, Aabed Baghat et al. · PLoS ONE Open access 11 Apr 2018 136
4 Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study Nathalie Goemans, M. Tulinius, M. van den Hauwe et al. · PLoS ONE Open access 2 Sep 2016 94
5 The expanded CAG repeat in the huntingtin gene as target for therapeutic RNA modulation throughout the HD mouse brain Nicole A. Datson, Anchel González‐Barriga, Eleni Kourkouta et al. · PLoS ONE Open access 9 Feb 2017 74
All 36 most cited papers, with filters and sorting

Which research topics does BioMarin (Netherlands) publish most on?

By volume in 2022-now: Cardiovascular Function and Risk Factors, Diabetes, Cardiovascular Risks, and Lipoproteins, Lipoproteins and Cardiovascular Health and Fibroblast Growth Factor Research.

Cardiovascular Function and Risk Factors: 0 fractional worksDiabetes, Cardiovascular Risks, and Lipoproteins: 0 fractional worksLipoproteins and Cardiovascular Health: 0 fractional worksFibroblast Growth Factor Research: 0 fractional worksHemophilia Treatment and Research: 0 fractional worksChronic Disease Management Strategies: 0 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 0 fractional worksHealthcare Policy and Management: 0 fractional worksMuscle Physiology and Disorders: 0 fractional worksRNA Interference and Gene Delivery: 0 fractional works
Cardiology and Cardiovascular MedicineEndocrinology, Diabetes and MetabolismSurgeryMolecular Biology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cardiovascular Function and Risk Factors Cardiology and Cardiovascular Medicine 0 works
  2. 2 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 0 works
  3. 3 Lipoproteins and Cardiovascular Health Surgery 0 works
  4. 4 Fibroblast Growth Factor Research Molecular Biology 0 works
  5. 5 Hemophilia Treatment and Research Hematology 0 works
  6. 6 Chronic Disease Management Strategies Epidemiology 0 works
  7. 7 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
  8. 8 Healthcare Policy and Management Economics and Econometrics 0 works
  9. 9 Muscle Physiology and Disorders Molecular Biology 0 works
  10. 10 RNA Interference and Gene Delivery Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available63.4%not open36.6%

World: 40% of research is openly available.

with international co-authors24.7%domestic only75.3%

World: 18% is written across borders.

How has BioMarin (Netherlands)'s research output changed?

Output in 2022-2025 was 79% lower than in 2018-2021.

still counting20202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is BioMarin (Netherlands) as a percentage of every work published that year, 0.0000061% in 2023.

still counting0.000050%0.00010%0.00015%BioMarin (Netherlands)0.0000029% in 20252020

Fractional works of BioMarin (Netherlands) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Leiden

All research institutions in Leiden

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about BioMarin (Netherlands). Posts are plain text and can be reported.